0001093557-22-000047.txt : 20220310 0001093557-22-000047.hdr.sgml : 20220310 20220310192421 ACCESSION NUMBER: 0001093557-22-000047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220308 FILED AS OF DATE: 20220310 DATE AS OF CHANGE: 20220310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dolan Matthew Vincent CENTRAL INDEX KEY: 0001914994 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 22730677 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-03-08 0 0001093557 DEXCOM INC DXCM 0001914994 Dolan Matthew Vincent 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 0 1 0 0 SVP Corporate Development Common Stock 2022-03-08 4 A 0 2889 0.001 A 10435 D Common Stock 2022-03-09 4 D 0 393 406.0567 D 10042 D Common Stock 2022-03-09 4 D 0 192 406.0567 D 9850 D Common Stock 2022-03-09 4 D 0 489 406.0567 D 9361 D Common Stock 2022-03-09 4 D 0 541 406.0567 D 8820 D Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. Included in this number are 6,634 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. By: Jereme Sylvain For: Matthew V Dolan 2022-03-10